HIGHLIGHTS
- who: Fdx and collaborators from the MicroPharm Ltd, United Kingdom Jilin University, China have published the research: Pan-cancer analyses con rmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker, in the Journal: (JOURNAL)
- what: This study demonstrated that copper could bind to and aggregate with lipoylated TCA cyclins, which then trigger proteotoxic stress along with the loss of Fe-S cluster proteins, resulting in cell death (Li et_al, 2022). Based on the above evidence, the authors focused on the relevant mechanisms of FDX1 in wide varieties of tumors, and conducted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.